To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.

3/18/2024, 10:18 PM

This bill excludes from gross income, for income tax purposes, any amount received by an individual as a qualified clinical trial payment. Such payments include amounts paid to an individual or a dependent of the individual as compensation for participation in an approved clinical trial (i.e., a trial conducted in relation to the prevention, detection, or treatment of cancer or other disease or condition) or as reimbursement or payment of reasonable and necessary expenses incurred in connection with the individual's participation in an approved clinical trial.

Congress
118

Number
HR - 7418

Introduced on
2024-02-20

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

2/20/2024

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

This bill excludes from gross income, for income tax purposes, any amount received by an individual as a qualified clinical trial payment. Such payments include amounts paid to an individual or a dependent of the individual as compensation for participation in an approved clinical trial (i.e., a trial conducted in relation to the prevention, detection, or treatment of cancer or other disease or condition) or as reimbursement or payment of reasonable and necessary expenses incurred in connection with the individual's participation in an approved clinical trial.

Alternative Names
Official Title as IntroducedTo amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.

Policy Areas
Taxation

Comments

Recent Activity

Latest Summary3/8/2024

This bill excludes from gross income, for income tax purposes, any amount received by an individual as a qualified clinical trial payment. Such payments include amounts paid to an individual or a dependent of the individual as compensation for pa...


Latest Action2/20/2024
Referred to the House Committee on Ways and Means.